Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-000828

Chief Financial Officer acquired 10,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2023-12-29 Option exercise +10,500 $6.88 $72,240 71,906 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Smith Hunter C Chief Financial Officer 2023-12-29 Option exercise · Stock Option (Right to Buy) −10,500 100,594 D: show line 2 in the form
Loading xslF345X05/tm2333854-2_4seq1.xml…